Ventricular tachycardia (VT) ablation is is a catheter-based technology used in the treatment of ventricular tachycardia. Despite widespread increase in the use of VT ablation, the impact of VT on subsequent hospitalization is unknown.

To assess rates and causes for reshospitalization after VT ablation.

The Truven Health MarketScan Research Databases capture person-specific clinical utilization, expenditures, and enrollment across inpatient and outpatient. We will query the database for all PVI procedures and determine subsequent rates of hospitalization.

STATA, SAS (Biostatistician is part of the project team.)

Heart Rhythm Society American College of Cardiology American Heart Association